Spain· ES:1221687001
ENJAYMO 50 MG/ML SOLUCION PARA PERFUSION
A medicinal product containing sutimlimab, registered in Spain by Recordati Rare Diseases.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- sutimlimab
- Manufacturer
- Recordati Rare Diseases
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sutimlimab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEnjaymo 1100 mg/22 ml, InfusionslösungRECORDATI AG
- CzechiaENJAYMORecordati Rare Diseases, Puteaux
- IrelandEnjaymo 50 mg/mL solution for infusionRecordati Rare Diseases
- IcelandEnjaymoRecordati Rare Diseases
- NorwayEnjaymoRecordati Rare Diseases
- PolandEnjaymoSanofi B.V.
- BelgiumEnjaymo 50 mg/mlRecordati Rare Diseases
- SwedenEnjaymo 50 mg/mL Infusionsvätska, lösningRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Enjaymo
- Liechtenstein · Enjaymo
- Norway · Enjaymo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cab93890-63f1-4a6d-a6fc-367cf0261350 GET /v1/drugs/cab93890-63f1-4a6d-a6fc-367cf0261350?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1767003433000}",
"nregistro": "1221687001",
"substance": "sutimlimab"
}See everything about sutimlimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.